Skip to main content

Table 1 Nivolumab and immune related adverse events

From: Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma

irAEs associated with nivolumab

Patient findings

Myalgias and arthralgias

Rhabdomyolysis

Hyperthyroidism

Elevated TSH

Ocular side effects

Keratoconjunctivitis

Hepatotoxicity

Transaminitis

Myocarditis

Troponin leak

Pleural effusion

Left lung consolidation with effusion

Myasthenia Gravis

Progressive weakness (related?)